Product NDC: | 68016-235 |
Proprietary Name: | Nasal Decongestant |
Non Proprietary Name: | Phenylephrine HCl |
Active Ingredient(s): | 10 mg/1 & nbsp; Phenylephrine HCl |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68016-235 |
Labeler Name: | Chain Drug Consortium, LLC (Premier Value) |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part341 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20100712 |
Package NDC: | 68016-235-15 |
Package Description: | 2 BLISTER PACK in 1 CARTON (68016-235-15) > 18 TABLET in 1 BLISTER PACK |
NDC Code | 68016-235-15 |
Proprietary Name | Nasal Decongestant |
Package Description | 2 BLISTER PACK in 1 CARTON (68016-235-15) > 18 TABLET in 1 BLISTER PACK |
Product NDC | 68016-235 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Phenylephrine HCl |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20100712 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | Chain Drug Consortium, LLC (Premier Value) |
Substance Name | PHENYLEPHRINE HYDROCHLORIDE |
Strength Number | 10 |
Strength Unit | mg/1 |
Pharmaceutical Classes |